The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines
NCT06124794
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
155
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL:
PROTOXIN
Sponsor
Protox Inc.